Atlas Trials

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece

Clinical trial NCT02618122 · COMPLETED

Trial details

NCT number
NCT02618122
Sponsor
Genesis Pharma S.A.
Status
COMPLETED
Study type
OBSERVATIONAL
Advanced Soft Tissue Sarcoma
Start date
2015-12-01
Primary completion
2019-06-30
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.